Liraglutide vs Octreotide
Overview
Liraglutide is primarily a weight management & metabolic peptide, while Octreotide is used for hormonal.
This page compares Liraglutide and Octreotide across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Liraglutide | Octreotide | |
|---|---|---|
| Category | Weight Management & Metabolic | Hormonal |
| Regulatory status (US) | FDA approved | FDA approved |
| Typical dosage | 0.6-3.0 mg | 20–30 mg (LAR formulation, IM every 4 weeks); 100–600 mcg/day in divided doses (immediate-release SC) |
| Frequency | daily | Every 4 weeks (LAR); two to four times daily (immediate-release) |
| Reported benefits | Weight loss, blood sugar control, cardiovascular protection | Reduction of growth hormone and IGF-1 in acromegaly, suppression of carcinoid flushing and diarrhea, control of VIPoma-associated watery diarrhea, antiproliferative effect on low-grade neuroendocrine tumors, reduction of urinary 5-HIAA biomarkers |
| Reported side effects | Nausea, GI disturbances, potential pancreatitis | Gallstones and biliary sludge, diarrhea, nausea, abdominal discomfort, sinus bradycardia, hyperglycemia, hypoglycemia, hypothyroidism, steatorrhea, injection-site pain |
Key differences
Primary use. Liraglutide is categorised under Weight Management & Metabolic, while Octreotide falls under Hormonal. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Liraglutide: FDA-approved. Octreotide: FDA-approved.
Dosing. Liraglutide is typically dosed at 0.6-3.0 mg (daily). Octreotide is typically dosed at 20–30 mg (LAR formulation, IM every 4 weeks); 100–600 mcg/day in divided doses (immediate-release SC) (Every 4 weeks (LAR); two to four times daily (immediate-release)).
Can you stack them?
Some protocols combine peptides, but stacking Liraglutide and Octreotide has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Liraglutide and Octreotide?
- Liraglutide is primarily a weight management & metabolic peptide, while Octreotide is used for hormonal. Liraglutide is FDA-approved for one or more indications, whereas Octreotide is FDA-approved for one or more indications.
- What is Liraglutide used for?
- FDA-approved GLP-1 for weight loss.
- What is Octreotide used for?
- FDA-approved somatostatin analog for acromegaly, carcinoid syndrome, and VIPomas since 1988.
- Can you take Liraglutide and Octreotide together?
- Some users combine peptides within a single protocol, but stacking Liraglutide and Octreotide has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Liraglutide or Octreotide FDA-approved?
- Liraglutide is FDA-approved for one or more indications. Octreotide is FDA-approved for one or more indications.
Read the full articles
- Liraglutide — full monograph: mechanism, research, dosing & references
- Octreotide — full monograph: mechanism, research, dosing & references